Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 16. Februar 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8801  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 176008  
   
Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: Current Evidence and Future Directions.
Int J Urol
Takahara K, Takeuchi A, Saruta M, Yoshizawa A, Nukaya T, Takenaka M, Ichino M, Sasaki H.
PMID: 41692947 [PubMed - indexed for MEDLINE]


Metabolism in Tumour-Induced Bone Disease.
Curr Osteoporos Rep
Ormsby RT, Edwards CM.
PMID: 41692878 [PubMed - indexed for MEDLINE]


Automated Classification of Kidney Tumours Using Deep Convolutional Neural Networks.
Int J Med Robot
Guo M, Lin S, You Y, Wei L.
PMID: 41691614 [PubMed - indexed for MEDLINE]


Association between baseline prostate MRI PI-RADS classification and risk of Gleason upgrade during active surveillance: a systematic review and meta-analysis.
World J Urol
Smani S, Sohoni N, Miszczyk M, Fazekas T, Rajwa P, Grimshaw AA, Sundaresan VM, Lokeshwar SD, Weinreb J, Sprenkle PC, Cooperberg MR, Seibert TM, Shariat SF, Catalona WJ, Leapman MS.
PMID: 41691567 [PubMed - indexed for MEDLINE]


Occupational Exposure to Welding Fumes and the Risk of Bladder Cancer: A Systematic Review and Meta-Analysis.
Am J Ind Med
Ryoo SW, Choi BY, Son SY, Lee JH, Kang MY.
PMID: 41691436 [PubMed - as supplied by publisher]


Interpretable habitat and peritumoral radiomics from multiparametric MRI for preoperative high-risk prostate cancer prediction: a multi-institutional study.
J Transl Med
Yuan M, Chang D, Lu W, Ma K, Gu Y, Xia T, Peng J, Zhang Y, Fu L, Zhao B.
PMID: 41691237 [PubMed - as supplied by publisher]


Prognostic value of the prognostic nutritional index for patients with renal cell carcinoma: an update systematic review and meta-analysis.
BMC Cancer
Xu Z, Xie L, Zhang H, Han G, Guo W.
PMID: 41691234 [PubMed - as supplied by publisher]


Spatiotemporal patterns and clustering of prostate cancer incidence in China: a Bayesian modeling study of cancer registry data.
BMC Public Health
Zhu X, Chen Z, Ge MW, Rehman AU, Chen HL, Zhu H, Zheng B.
PMID: 41691228 [PubMed - as supplied by publisher]


Surgery or Radiotherapy: Determining Factors in Therapeutic Decision-Making for Localized Prostate Cancer in Spain.
Actas Urol Esp (Engl Ed)
Perez-Ardavin J, Vera-Donoso CD, Alapont JM, Martinez-Sarmiento M, Monserrat JJ, Ruíz Cerdá JL, Conde AJ, Budía Alba A.
PMID: 41690467 [PubMed - as supplied by publisher]


Bladder and rectal cancer development in prostate cancer patients treated with surgery or radiotherapy: A population-based study.
Actas Urol Esp (Engl Ed)
Martínez Rodríguez P, Poza Fernandez A, García Fadrique G, Acedo González J, Montero Adriá O, Mateo Cárcel N, Marzullo Zucchet L, Gómez Palomo F, Reig Ruiz C.
PMID: 41690466 [PubMed - as supplied by publisher]


Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.
Radiother Oncol
Michalet M, Ronchin P, Reynaud T, Demogeot N, Gourgou S, Thézenas S, Hannoun-Lévi JM, Salem N, Quivrin M, Riou O, Charissoux M, Llacer-Moscardo C, Tosi D, Durdux C, Khalladi N, Culine S, Azria D.
PMID: 41690405 [PubMed - as supplied by publisher]


Optimal adjuvant intravesical therapy for intermediate risk non-muscle invasive bladder cancer; oncological and patient-reported outcomes of randomized controlled trial.
Urol Oncol
Elsawy AA, Laymon M, Ezzat O, Mansour I, Sobh AA, Nour EA, Mosbah A.
PMID: 41689868 [PubMed - as supplied by publisher]


MiRNA based liquid biopsy for castration-resistant prostate cancer diagnostics.
Mol Cell Biochem
Konoshenko MY, Saitkulova MM, Shutko EV, Ostaltsev IA, Laktionov PP, Bryzgunova OE.
PMID: 41689709 [PubMed - as supplied by publisher]


Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives.
Discov Oncol
Giunta EF, Schepisi G, Bleve S, Serra R, Brighi N, Torresan I, Tassinari E, Zanuccoli S, Lolli C.
PMID: 41689691 [PubMed - as supplied by publisher]


Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25.
Cancer Immunol Immunother
Roviello G, Gambale E, De Gennaro Aquino I, Maruzzo M, Messina C, Vascotto IA, Rossi V, Bimbatti D, Erbetta E, Messina M, Mennitto A, Rebuzzi SE, Nasso C, Mercinelli C, Catalano M, Maiorano BA, Fanelli M, Sorarù M, Scolari F, Mela MM, Galli L, Salfi A, Rizzo M, Puglisi S, Orlando V, Fornarini G, Rametta A, Giannatempo P, Cerbone L, Doni L, Pillozzi S, Antonuzzo L.
PMID: 41689638 [PubMed - indexed for MEDLINE]


Pharmacokinetics and Dosimetry of [(68)Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study.
Cancer Biother Radiopharm
Fan W, Li Y, Shi H, Guo J, Huang R, Dong Q, Yang Z, Yang Y, Wang X, Gu D, Ye D, Wang F, Wang J, Xu D, Jiang Z, Li H, Li J, Li R, Huo L, Ji Z.
PMID: 41689461 [PubMed - as supplied by publisher]


The Modified Frailty Index-5 as a Predictor of Postoperative Complications Following Radical Cystectomy.
J Coll Physicians Surg Pak
Dincer E, Ozkaptan O, Canakci C, Ipek OM, Coskun A, Can U.
PMID: 41689329 [PubMed - indexed for MEDLINE]


Magnetic resonance-guided simultaneous multi-fo​cal adaptive radiotherapy for prostate, pElvis & metastases (MRgSMART-PEM) in prostate cancer: a prospective phase II study.
Radiat Oncol
Sun M, Qin SR, Wei R, Tian Y, Yan LL, Xia WL, Liu ZQ, Fu Q, Song YW, Fang H, Jing H, Wang SL, Li YX, Xing NZ, Lu NN.
PMID: 41689033 [PubMed - as supplied by publisher]


Contemporary Role for Blue Light Cystoscopy Across the Bladder Cancer Disease Spectrum.
Curr Urol Rep
Wan E, Wade C, Sathe A, Ferguson JE 3rd, Peyton CC.
PMID: 41688839 [PubMed - in process]


The Relationship Between Prostate Cancer Treatments and Changes to Musculature: A Systematic Review.
Clin Oncol (R Coll Radiol)
Partridge L, Vickers A, McSweeney D, Shortall J, McWilliam A.
PMID: 41688299 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 176008    Seite 1 von 8801  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1